Roche Korea said on March 10 that it has launched its breakthrough drug Pegasys for the treatment of chronic hepatitis C with convenient one-weekly dosing.
In a launching ceremony for Pegasys on March 10, Prof. Yoon Seung-kyu, medical college of Catholic University, said, The entry of Pegasys into the hepatitis C treatment arena signified a remarkable advance, as it has fewer side effects th...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.